LINDAHL RICHARD S
Insider CIK 1196632 · EXBD Chief Financial Officer · EBS EVP, Chief Financial Officer · CMPX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2026-06-08 | 2026-06-10 | 3,964 | $8.00 | $31.7K | 374,083 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2026-04-29 | 2026-05-01 | 162,680 | — | $0 | 378,047 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2026-03-05 | 2026-03-05 | 23,650 | $8.44 | $199.6K | 215,367 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2026-03-03 | 2026-03-05 | 72,856 | — | $0 | 557,346 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2026-03-01 | 2026-03-03 | 683 | $8.15 | $5.6K | 239,017 | SEC↗ |
| EBS Emergent BioSolutions Inc. | H Expire deriv | 2026-02-25 | 2026-03-06 | 20,321 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2026-02-06 | 2026-02-10 | 5,642 | $10.92 | $61.6K | 239,700 | SEC↗ |
| EBS Emergent BioSolutions Inc. | D To issuer | 2026-02-06 | 2026-02-10 | 46,155 | $10.92 | $504.0K | 245,342 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2025-10-15 | 2025-10-17 | 4,995 | $9.60 | $48.0K | 291,497 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2025-06-08 | 2025-06-10 | 2,733 | $6.63 | $18.1K | 296,492 | SEC↗ |
| EBS Emergent BioSolutions Inc. | H Expire deriv | 2025-05-07 | 2026-03-06 | 19,963 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2025-03-06 | 2025-03-10 | 178,546 | — | $0 | 484,490 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2025-03-06 | 2025-03-10 | 146,888 | — | $0 | 299,225 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2025-03-01 | 2025-03-04 | 683 | $7.48 | $5.1K | 152,337 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2025-02-28 | 2025-03-04 | 1,073 | $7.48 | $8.0K | 153,020 | SEC↗ |
| EBS Emergent BioSolutions Inc. | D To issuer | 2025-02-12 | 2025-03-04 | 16,916 | — | $0 | 154,093 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2025-02-11 | 2025-02-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2024-10-15 | 2024-10-17 | 15,000 | — | $0 | 171,009 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2024-06-08 | 2024-06-11 | 2,733 | $6.19 | $16.9K | 156,009 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2024-03-13 | 2024-03-15 | 125,000 | — | $0 | 305,944 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2024-03-01 | 2024-03-04 | 684 | $3.39 | $2.3K | 158,742 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2024-02-29 | 2024-03-04 | 9,037 | $3.23 | $29.2K | 159,426 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2024-02-23 | 2024-02-27 | 517 | $2.74 | $1.4K | 168,463 | SEC↗ |
| EBS Emergent BioSolutions Inc. | D To issuer | 2024-02-21 | 2024-02-27 | 4,012 | $2.71 | $10.9K | 168,980 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2024-02-09 | 2024-02-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2023-06-09 | 2023-06-13 | 49,231 | — | $0 | 180,944 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2023-06-09 | 2023-06-13 | 24,616 | — | $0 | 123,761 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2023-06-09 | 2023-06-13 | 49,231 | — | $0 | 172,992 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2023-04-21 | 2023-04-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2023-03-02 | 2023-03-06 | 12,308 | — | $0 | 93,049 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2023-03-02 | 2023-03-06 | 6,154 | — | $0 | 86,837 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2023-03-02 | 2023-03-06 | 12,308 | — | $0 | 99,145 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2023-02-28 | 2023-03-02 | 1,074 | $12.38 | $13.3K | 16,906 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2023-02-24 | 2023-02-27 | 977 | $13.71 | $13.4K | 17,980 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2023-02-23 | 2023-02-27 | 444 | $14.30 | $6.3K | 18,957 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2023-02-08 | 2023-02-10 | 2,396 | $13.25 | $31.7K | 19,401 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2023-02-08 | 2023-02-10 | 101 | — | $0 | 21,797 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2022-03-01 | 2022-03-02 | 38,664 | $41.38 | $1.60M | 38,664 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2022-03-01 | 2022-03-02 | 16,916 | — | $0 | 86,291 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2022-03-01 | 2022-03-02 | 31,417 | — | $0 | 69,375 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2022-02-28 | 2022-03-02 | 818 | $39.64 | $32.4K | 85,473 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2022-02-24 | 2022-02-25 | 983 | $42.47 | $41.7K | 37,958 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2022-02-23 | 2022-02-25 | 516 | $42.23 | $21.8K | 38,941 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2022-02-22 | 2022-02-24 | 2,298 | $42.23 | $97.0K | 39,457 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2022-02-22 | 2022-02-24 | 1,836 | — | $0 | 41,755 | SEC↗ |
| EBS Emergent BioSolutions Inc. | P Buy | 2021-11-15 | 2021-11-15 | 3,000 | $37.46 | $112.4K | 39,919 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2021-05-08 | 2021-05-11 | 1,054 | $61.62 | $64.9K | 36,919 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2021-02-26 | 2021-02-26 | 819 | $97.15 | $79.6K | 37,973 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2021-02-24 | 2021-02-26 | 16,043 | $93.49 | $1.50M | 16,043 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2021-02-24 | 2021-02-26 | 4,011 | — | $0 | 35,790 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2021-02-24 | 2021-02-26 | 4,012 | — | $0 | 39,802 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2021-02-24 | 2021-02-26 | 1,010 | $93.49 | $94.4K | 38,792 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2021-02-09 | 2021-02-11 | 2,495 | — | $0 | 34,301 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2021-02-09 | 2021-02-11 | 2,522 | $123.45 | $311.3K | 31,779 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2020-05-08 | 2020-05-12 | 728 | $79.25 | $57.7K | 31,806 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2020-02-26 | 2020-02-27 | 610 | $59.91 | $36.5K | 32,534 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2020-02-25 | 2020-02-27 | 24,414 | $61.44 | $1.50M | 44,735 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2020-02-25 | 2020-02-27 | 6,103 | — | $0 | 27,040 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2020-02-25 | 2020-02-27 | 6,104 | — | $0 | 33,144 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2019-05-08 | 2019-05-10 | 759 | $47.49 | $36.0K | 20,937 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2019-02-26 | 2019-02-28 | 20,321 | $61.01 | $1.24M | 20,321 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2019-02-26 | 2019-02-28 | 5,081 | — | $0 | 21,696 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2019-02-26 | 2019-02-28 | 5,081 | — | $0 | 16,615 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2018-05-08 | 2018-05-10 | 19,963 | $48.33 | $964.8K | 19,963 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2018-05-08 | 2018-05-10 | 1,551 | — | $0 | 6,543 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2018-05-08 | 2018-05-10 | 4,991 | — | $0 | 11,534 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2018-05-08 | 2018-05-10 | 4,992 | — | $0 | 4,992 | SEC↗ |
| CEB CEB Inc. | M Exercise deriv | 2017-04-05 | 2017-04-06 | 23,435 | — | $0 | 0 | SEC↗ |
| CEB CEB Inc. | M Exercise deriv | 2017-04-05 | 2017-04-06 | 7,686 | — | $0 | 0 | SEC↗ |
| CEB CEB Inc. | D To issuer | 2017-04-05 | 2017-04-06 | 6,433 | — | $0 | 37,852 | SEC↗ |
| CEB CEB Inc. | D To issuer | 2017-04-05 | 2017-04-06 | 37,852 | — | $0 | 0 | SEC↗ |
| CEB CEB Inc. | M Exercise | 2017-04-05 | 2017-04-06 | 7,686 | — | $0 | 45,538 | SEC↗ |
| CEB CEB Inc. | F Tax w/h | 2017-04-05 | 2017-04-06 | 1,253 | $78.85 | $98.8K | 44,285 | SEC↗ |
| CEB CEB Inc. | M Exercise deriv | 2017-03-27 | 2017-03-29 | 2,208 | — | $0 | 0 | SEC↗ |
| CEB CEB Inc. | M Exercise deriv | 2017-03-27 | 2017-03-29 | 1,749 | — | $0 | 1,749 | SEC↗ |
| CEB CEB Inc. | M Exercise deriv | 2017-03-27 | 2017-03-29 | 2,051 | — | $0 | 4,102 | SEC↗ |
| CEB CEB Inc. | F Tax w/h | 2017-03-27 | 2017-03-29 | 744 | $78.90 | $58.7K | 37,852 | SEC↗ |
| CEB CEB Inc. | M Exercise | 2017-03-27 | 2017-03-29 | 6,008 | — | $0 | 38,596 | SEC↗ |
| CEB CEB Inc. | A Award deriv | 2017-03-15 | 2017-03-17 | 7,561 | — | $0 | 7,561 | SEC↗ |
| CEB CEB Inc. | M Exercise deriv | 2017-02-17 | 2017-02-21 | 2,255 | — | $0 | 0 | SEC↗ |
| CEB CEB Inc. | M Exercise | 2017-02-17 | 2017-02-21 | 2,255 | — | $0 | 32,588 | SEC↗ |
| CEB CEB Inc. | M Exercise deriv | 2016-04-25 | 2016-04-27 | 2,052 | — | $0 | 6,153 | SEC↗ |
| CEB CEB Inc. | F Tax w/h | 2016-04-25 | 2016-04-27 | 744 | $64.85 | $48.2K | 30,333 | SEC↗ |
| CEB CEB Inc. | M Exercise | 2016-04-25 | 2016-04-27 | 2,052 | — | $0 | 31,077 | SEC↗ |
| CEB CEB Inc. | A Award deriv | 2016-03-30 | 2016-04-01 | 10,023 | — | $0 | 10,023 | SEC↗ |
| CEB CEB Inc. | A Award deriv | 2016-03-30 | 2016-04-01 | 4,233 | — | $0 | 4,233 | SEC↗ |
| CEB CEB Inc. | M Exercise deriv | 2016-03-28 | 2016-03-30 | 1,749 | — | $0 | 3,498 | SEC↗ |
| CEB CEB Inc. | M Exercise deriv | 2016-03-28 | 2016-03-30 | 2,208 | — | $0 | 2,208 | SEC↗ |
| CEB CEB Inc. | M Exercise deriv | 2016-03-28 | 2016-03-30 | 2,388 | — | $0 | 0 | SEC↗ |
| CEB CEB Inc. | M Exercise | 2016-03-28 | 2016-03-30 | 6,345 | — | $0 | 29,891 | SEC↗ |
| CEB CEB Inc. | F Tax w/h | 2016-03-28 | 2016-03-30 | 866 | $62.52 | $54.1K | 29,025 | SEC↗ |
| CEB CEB Inc. | M Exercise deriv | 2016-02-19 | 2016-02-23 | 3,027 | — | $0 | 0 | SEC↗ |
| CEB CEB Inc. | M Exercise | 2016-02-19 | 2016-02-23 | 3,027 | — | $0 | 23,546 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2015-04-27 | 2015-04-28 | 1,750 | — | $0 | 5,247 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise | 2015-04-27 | 2015-04-28 | 1,750 | — | $0 | 20,519 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2015-03-30 | 2015-03-31 | 2,388 | — | $0 | 2,388 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2015-03-30 | 2015-03-31 | 2,557 | — | $0 | 0 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | F Tax w/h | 2015-03-30 | 2015-03-31 | 1,794 | $80.02 | $143.6K | 18,769 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise | 2015-03-30 | 2015-03-31 | 4,945 | — | $0 | 20,563 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2015-03-27 | 2015-03-31 | 2,208 | — | $0 | 4,416 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise | 2015-03-27 | 2015-03-31 | 2,208 | — | $0 | 15,618 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | A Award deriv | 2015-03-25 | 2015-03-27 | 3,453 | — | $0 | 3,453 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | A Award deriv | 2015-03-25 | 2015-03-27 | 8,205 | — | $0 | 8,205 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2015-02-20 | 2015-02-24 | 5,056 | — | $0 | 0 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise | 2015-02-20 | 2015-02-24 | 5,056 | — | $0 | 15,275 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | F Tax w/h | 2015-02-20 | 2015-02-24 | 1,865 | $79.19 | $147.7K | 13,410 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | S Sale | 2014-08-01 | 2014-08-01 | 6,300 | $61.75 | $389.0K | 10,219 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | S Sale | 2014-07-31 | 2014-08-01 | 8,700 | $61.76 | $537.3K | 16,519 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2014-04-28 | 2014-04-30 | 2,209 | — | $0 | 6,624 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise | 2014-04-28 | 2014-04-30 | 2,209 | — | $0 | 25,219 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2014-03-31 | 2014-04-01 | 1,959 | — | $0 | 0 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2014-03-31 | 2014-04-01 | 2,557 | — | $0 | 2,557 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | F Tax w/h | 2014-03-31 | 2014-04-01 | 1,639 | $74.23 | $121.7K | 23,010 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise | 2014-03-31 | 2014-04-01 | 4,516 | — | $0 | 24,649 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2014-03-28 | 2014-04-01 | 2,388 | — | $0 | 4,776 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise | 2014-03-28 | 2014-04-01 | 2,388 | — | $0 | 20,989 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | F Tax w/h | 2014-03-28 | 2014-04-01 | 856 | $72.75 | $62.3K | 20,133 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | A Award deriv | 2014-03-26 | 2014-03-27 | 2,819 | — | $0 | 2,819 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | A Award deriv | 2014-03-26 | 2014-03-27 | 6,997 | — | $0 | 6,997 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2013-06-10 | 2013-06-11 | 3,677 | — | $0 | 0 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2013-06-10 | 2013-06-17 | 3,677 | — | $0 | 0 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | F Tax w/h | 2013-06-10 | 2013-06-11 | 1,702 | $61.13 | $104.0K | 18,770 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise | 2013-06-10 | 2013-06-11 | 3,677 | — | $0 | 20,472 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | F Tax w/h | 2013-06-10 | 2013-06-17 | 1,871 | $61.13 | $114.4K | 18,601 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise | 2013-06-10 | 2013-06-17 | 3,677 | — | $0 | 20,472 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2013-04-29 | 2013-05-01 | 2,389 | — | $0 | 7,164 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | F Tax w/h | 2013-04-29 | 2013-05-01 | 867 | $56.31 | $48.8K | 16,795 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise | 2013-04-29 | 2013-05-01 | 2,389 | — | $0 | 17,662 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2013-04-01 | 2013-04-02 | 2,558 | — | $0 | 5,114 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2013-04-01 | 2013-04-02 | 1,959 | — | $0 | 1,959 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | M Exercise | 2013-04-01 | 2013-04-02 | 4,517 | — | $0 | 16,902 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | F Tax w/h | 2013-04-01 | 2013-04-02 | 1,629 | $57.13 | $93.1K | 15,273 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | A Award deriv | 2013-03-27 | 2013-03-28 | 3,561 | — | $0 | 3,561 | SEC↗ |
| CEB CORPORATE EXECUTIVE BOARD | A Award deriv | 2013-03-27 | 2013-03-28 | 8,833 | — | $0 | 8,833 | SEC↗ |
| EXBD CORPORATE EXECUTIVE BOARD | P Buy | 2012-11-20 | 2012-11-20 | 1,000 | $41.50 | $41.5K | 12,385 | SEC↗ |
| EXBD CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2012-06-11 | 2012-06-12 | 3,678 | — | $0 | 3,677 | SEC↗ |
| EXBD CORPORATE EXECUTIVE BOARD | M Exercise | 2012-06-11 | 2012-06-12 | 3,678 | — | $0 | 12,677 | SEC↗ |
| EXBD CORPORATE EXECUTIVE BOARD | F Tax w/h | 2012-06-11 | 2012-06-12 | 1,292 | $37.99 | $49.1K | 11,385 | SEC↗ |
| EXBD CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2012-04-30 | 2012-05-01 | 2,558 | — | $0 | 7,672 | SEC↗ |
| EXBD CORPORATE EXECUTIVE BOARD | F Tax w/h | 2012-04-30 | 2012-05-01 | 899 | $41.37 | $37.2K | 8,999 | SEC↗ |
| EXBD CORPORATE EXECUTIVE BOARD | M Exercise | 2012-04-30 | 2012-05-01 | 2,558 | — | $0 | 9,898 | SEC↗ |
| EXBD CORPORATE EXECUTIVE BOARD | M Exercise deriv | 2012-04-02 | 2012-04-03 | 1,959 | — | $0 | 3,918 | SEC↗ |
| EXBD CORPORATE EXECUTIVE BOARD | F Tax w/h | 2012-04-02 | 2012-04-03 | 688 | $43.15 | $29.7K | 7,340 | SEC↗ |
| EXBD CORPORATE EXECUTIVE BOARD | M Exercise | 2012-04-02 | 2012-04-03 | 1,959 | — | $0 | 8,028 | SEC↗ |
| EXBD CORPORATE EXECUTIVE BOARD | A Award deriv | 2012-03-28 | 2012-03-29 | 9,553 | — | $0 | 9,553 | SEC↗ |
| EXBD CORPORATE EXECUTIVE BOARD | A Award deriv | 2012-03-28 | 2012-03-29 | 4,776 | — | $0 | 4,776 | SEC↗ |